Connect with us

Business

CSL (ASX:CSL) share price wobbles on COVID vaccine news – The Motley Fool Australia

The CSL Limited (ASX: CSL) share price is on watch after the UK found “possible links” between the AstraZeneca vaccine and blood clots.

Published

on

Article feature image

The CSL Limited (ASX: CSL) share price is a little wobbly this morning after negative vaccine news overnight from the United Kingdom.
The pharmaceutical giant, which produces and supplies the AstraZeneca PLC (LSE: AZ)COVID-19 vaccine in Australia, is trading close to its opening price after news that the UK medical regulator has found a “possible link” between the vaccine and blood clotting in younger adults. The regulator noted that blood clotting was considered a rare side-effect of the vaccine.

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Why this outstanding ETF deserves the attention of ASX investors
Why the AVITA (ASX:AVH) share price is charging higher today